Switch to:
More From Other Websites
Myriad Genetics Announces Five Scientific Presentations at the 2017 American College of Medical... Mar 20 2017
Myriad Genetics (MYGN) Launches EndoPredict Test in the US Mar 14 2017
Myriad Genetics Launches the EndoPredict® Test in the United States for Patients with Breast Cancer Mar 13 2017
Why Is Myriad Genetics (MYGN) Up 15.8% Since the Last Earnings Report? Mar 10 2017
Bullish and Bearish Reversals in the Market Feb 27 2017
Post Earnings Coverage as Myriad's Q2 Top-line Grew 2%; Topped Estimates Feb 27 2017
GeneSight® Psychotropic Test Demonstrated Substantial Cost Savings for Payers in New Study... Feb 23 2017
Myriad’s BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with... Feb 17 2017
Myriad’s Prolaris® Test Significantly Improves the Risk Classification for One Third of Men... Feb 17 2017
Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : February... Feb 14 2017
MYRIAD GENETICS INC Financials Feb 11 2017
Myriad Genetics to Join S&P SmallCap 600 Feb 10 2017
Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q2, 2017 By the Numbers : February 9, 2017 Feb 09 2017
Myriad Genetics (MYGN): Q2 Impressive, 2017 View a Drag Feb 09 2017
MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report Feb 08 2017
Wednesday’s Biggest Biopharma Movers Feb 08 2017
Myriad Genetics: Fairly Valued? Feb 08 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)